Literature DB >> 19328914

Indoleamine 2,3-dioxygenase and foxp3 expression in skin rejection of human hand allografts.

T Hautz1, G Brandacher, B Zelger, H G Müller, A W P Lee, D Fuchs, R Margreiter, S Schneeberger.   

Abstract

Human hand transplantation is complicated by skin rejection. To better define the characteristics of infiltrating cells, biopsies from human hand transplants have been investigated for expression of Foxp3 and indoleamine 2,3-dioxygenase (IDO), a key regulatory enzyme to induce T-lymphocyte unresponsiveness. A total of 104 skin biopsies taken from three bilateral hand transplant recipients over 6 years posttransplant were assessed by hematoxylin-eosin histology (graded 1-4b) and immunohistochemistry for IDO and Foxp3 according to a three-grade classification and correlated with the grade of rejection as well as time after transplantation. Overall, rejection ranged between grades 0 and 4a with an average score of 0.94. IDO was expressed in the endothelium independent of rejection. Upon rejection, IDO staining within the cellular infiltrate was significantly increased. Foxp3 in regulatory T cells was mainly found in samples undergoing severe rejection. Expression of IDO and Foxp3 compared well to each other, although the overall expression of Foxp3 was lower when compared to IDO. An increased expression of IDO as well as Foxp3 during rejection late after transplantation was observed. Characteristics of the cellular infiltrate indicate tolerogenic properties of a proportion of the cells and therefore a tendency toward self-limitation of the alloimmune response during skin rejection after hand transplantation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19328914     DOI: 10.1016/j.transproceed.2009.01.008

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  6 in total

1.  Combined treatment with regulatory T cells and vascularized bone marrow transplantation creates mixed chimerism and induces donor-specific tolerance to vascularized composite allografts without cytoreductive conditioning.

Authors:  Jeng-Yee Lin; Feng-Chou Tsai; Christopher Glenn Wallace; Wei-Chao Huang; Fu-Chan Wei; Shuen-Kuei Liao
Journal:  Chimerism       Date:  2013 Jan-Mar

2.  Effects of Foxp3 gene modified dendritic cells on mouse corneal allograft rejection.

Authors:  Yu-Bo Gong; Lian-Na Hu; Yong Liu; Gen-Cheng Han; Hui-Ling Guo; Ling Luo; Li-Qiang Wang; Yan Li; Yi-Fei Huang
Journal:  Int J Clin Exp Med       Date:  2015-03-15

3.  A Flow Dynamic Rationale for Accelerated Vascularized Composite Allotransplant Rejection.

Authors:  Nicholas L Robbins; Matthew J Wordsworth; Bijaya K Parida; Bruce Kaplan; Vijay S Gorantla; Col Erik K Weitzel; Warren C Breidenbach
Journal:  Plast Reconstr Surg       Date:  2019-03       Impact factor: 4.730

Review 4.  Improving the safety of tolerance induction: chimerism and cellular co-treatment strategies applied to vascularized composite allografts.

Authors:  Wei-Chao Huang; Jeng-Yee Lin; Christopher Glenn Wallace; Fu-Chan Wei; Shuen-Kuei Liao
Journal:  Clin Dev Immunol       Date:  2012-10-22

Review 5.  The need for inducing tolerance in vascularized composite allotransplantation.

Authors:  Kadiyala V Ravindra; Hong Xu; Larry D Bozulic; David D Song; Suzanne T Ildstad
Journal:  Clin Dev Immunol       Date:  2012-10-31

6.  Long-term outcome after hand and forearm transplantation - a retrospective study.

Authors:  Theresa Hautz; Franka Messner; Annemarie Weissenbacher; Hubert Hackl; Martin Kumnig; Marina Ninkovic; Valeria Berchtold; Johanna Krapf; Bettina G Zelger; Bernhard Zelger; Dolores Wolfram; Gerhard Pierer; Wolfgang N Löscher; Robert Zimmermann; Markus Gabl; Rohit Arora; Gerald Brandacher; Raimund Margreiter; Dietmar Öfner; Stefan Schneeberger
Journal:  Transpl Int       Date:  2020-11-10       Impact factor: 3.842

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.